Virax Biolabs Group Limited Ordinary Shares Financial Flexibility Index
Virax Biolabs Group Limited Ordinary Shares financial flexibility index. Virax Biolabs Group Limited Ordinary Shares (VRAX) has a Financial Flexibility Index of -4.34x as of September 2025. Free cash flow of $-2.78 Million (operating CF $-2.92 Million minus capex $141.50K) represents -4% of total liabilities ($641.52K).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Virax Biolabs Group Limited Ordinary Shares (2020–2025)
Financial flexibility index of Virax Biolabs Group Limited Ordinary Shares from 2020 to 2025. Historical Financial Flexibility Index trend for Virax Biolabs Group Limited Ordinary Shares across 6 annual periods. Explore cash flow to debt ratio of Virax Biolabs Group Limited Ordinary Sha to assess how comfortably operating cash covers total debt obligations.
Virax Biolabs Group Limited Ordinary Shares Financial Flexibility Index by Year (2020–2025)
Virax Biolabs Group Limited Ordinary Shares financial flexibility index by year from 2020 to 2025. Year-by-year free cash flow to debt coverage for Virax Biolabs Group Limited Ordinary Shares. For the full cash flow conversion analysis, see VRAX cash generation efficiency.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -4.10x | $-3.96 Million | $-4.56 Million | $964.75K | ▲ +72.1% |
| 2024 | -14.72x | $-5.08 Million | $-6.25 Million | $345.19K | ▼ -234.3% |
| 2023 | -4.40x | $-4.00 Million | $-4.18 Million | $908.40K | ▼ -578.0% |
| 2022 | -0.65x | $-809.07K | $-809.07K | $1.25 Million | ▲ +4.1% |
| 2021 | -0.68x | $-590.19K | $-590.19K | $871.43K | ▼ -12.6% |
| 2020 | -0.60x | $-744.61K | $-744.61K | $1.24 Million | — |